Andocksysteme will be at CPHI Milan 2026, October 6 to 8 at Fiera Milano, joining its partner Shandong SMA Pharmatech at their stand. The Andocksysteme Containment Specialists are on site for all three days alongside SMA, a manufacturer of solid dose and containment systems for pharmaceutical production. Visitors can review contained powder transfer solutions in the context of a full processing line, from process equipment to the docking interface.
The Andocksysteme containment portfolio is covered at the stand: the ASBV multi-use split butterfly valve (MUT) and the AVAX single-use split butterfly valve (SUT). Both systems are designed for contained powder transfer in pharmaceutical and fine chemical manufacturing, validated to Occupational Exposure Limit (OEL) <1.0 µg/m³ by SMEPAC testing (ISPE standardized surrogate powder test). Process specifications can be reviewed and discussed on site.
Meet the Andocksysteme team at Shandong SMA Pharmatech's stand
Shandong SMA Pharmatech is exhibiting for all three days of CPHI Milan 2026, October 6 to 8, at Fiera Milano in Milan. The Andocksysteme Containment Specialists join SMA at the stand to discuss containment sizing, application fit, and qualification documentation directly.
Register to attend CPHI Milan 2026 at cphi.com/europe.
To arrange a meeting ahead of the exhibition, contact the Andocksysteme team at info@andocksysteme.de.
What is CPHI Milan and why is Andocksysteme there?
CPHI Milan is the pharmaceutical industry’s largest annual gathering. The 2026 edition, the 35th, brings together more than 2,900 exhibiting companies and over 62,000 attendees from 166 countries at Fiera Milano, organized by Informa Markets. The program spans the full supply chain, from active pharmaceutical ingredients and finished dosage to machinery, packaging, and biopharmaceuticals.
Andocksysteme’s ASBV split butterfly valve achieves OEL <1.0 µg/m³ per ISPE SMEPAC testing, independently verified by third-party laboratories. FDA, EMA, and MHRA inspectors request this containment performance level as primary evidence during facility qualification audits. Through the partnership with Shandong SMA Pharmatech, Andocksysteme containment technology is presented within a complete solid dose and containment offering, giving manufacturers a single point to specify the transfer interface alongside the surrounding process equipment.